{"disease":{"id":"low-risk-differentiated-thyroid-cancer","name":"low risk differentiated thyroid cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01837745","title":"Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":776,"lead_sponsor_name":"Gustave Roussy, Cancer Campus, Grand Paris","has_results":false},{"nct_id":"NCT05510934","title":"Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Nova Scotia Health Authority","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}